首页> 外文期刊>Molecular pharmaceutics >Encapsulation of an EP67-Conjugated CTL Peptide Vaccine in Nanoscale Biodegradable Particles Increases the Efficacy of Respiratory Immunization and Affects the Magnitude and Memory Subsets of Vaccine-Generated Mucosal and Systemic CD8(+) T Cells in a Diameter-Dependent Manner
【24h】

Encapsulation of an EP67-Conjugated CTL Peptide Vaccine in Nanoscale Biodegradable Particles Increases the Efficacy of Respiratory Immunization and Affects the Magnitude and Memory Subsets of Vaccine-Generated Mucosal and Systemic CD8(+) T Cells in a Diameter-Dependent Manner

机译:纳米级可生物降解颗粒中的EP67缀合的CTL肽疫苗的封装增加了呼吸免疫的功效,并影响疫苗产生的粘膜和全身CD8(+)T细胞的幅度和记忆亚组以直径依赖性的方式

获取原文
获取原文并翻译 | 示例
       

摘要

The diameter of biodegradable particles used to coencapsulate immunostirmilants and subunit vaccines affects. the magnitude of memory CD8(+) T cells generated by systemic immunization. Possible effects on the magnitude of CD8(+) T cells generated by mucosal immunization or memory subsets that potentially correlate more, strongly with,protection against certain pathogens, however, are unknown. In this study, we conjugated our novel host-derived mucosal inimunostimulant, EP67, to the protective MCMV CTL epitope, pp89, through alysosomal protease-labile double arginine linker,(pp89-RR-EP67) and encapsulated in PLGA 50:,50 micro- or -nanoparicles. We then compared total magnitude, effector/central memory (CD127/KRLG1/CD62L), and IFN-gamma/TNE-alpha/IL.2 secreting subsets of pp89-specific CD8(+) T cells.as well as protection of naive female BALB/c mice against primary respiratory infection with MCMV 21 days' after respiratory immunization. We found that decreasing the diameter of encapsulating particle from,hem to rim '(i) increased the magnitude of pp89-specific CD8+ T cells in the lungs and spleen; (ii) partially changed, CD127/KLRG1 effector memory subsets in the lungs but riot the Spleen; (iii) changed CD127/KRLG1/CD62L effector/central memory subsets in the spleen;' (iv) changed pp89=resperisive IFN.gamma/TNF-alpha/IL-2 secreting subsets the lungs and spleen; (v) did not affect the extent to which encapsulation increased efficacy against primary MCMV respiratory infection over uneneapsulated pp89-RR-EP67. Thus, although not observed under Our current experimental conditions with MCMV, varying the diameter of nanoscale biodegradable particles may increase the efficacy of mucosal immunization with coencapsulated immimostimulant/subunit vaccines against certain pathogens by selectively increasing memory subset(s) of-CD8+ T cells that correlate the strongest with protection.
机译:可生物降解颗粒的直径,用于携带免疫血压和亚基疫苗的影响。通过全身免疫产生的记忆CD8(+)T细胞的大小。然而,对粘膜免疫或存储亚群产生的CD8(+)T细胞幅度的可能影响,可能与某些病原体的保护更多,强烈地保护,但是未知。在这项研究中,我们将我们的新型宿主源性粘液抑制肥,EP67缀合到保护性MCMV CTL表位PP89,PP89通过烯皂组蛋白酶蛋白酶 - 不稳定的双精氨酸连接物(PP89-RR-EP67)并在PLGA 50中包封,50微米 - 或 - 纳米泛基。然后,我们将总幅度,效应/中央记忆(CD127 / KrlG1 / CD62L)和IFN-Gamma / TNE-α/ IL.2分泌PP89特异性CD8(+)T细胞的分泌亚组。以及保护Naive女性的保护呼吸免疫后,BALB / C小鼠对MCMV 21天的原发性呼吸道感染。我们发现,从悬浮液到边缘的封装粒子的直径降低,悬垂粒子(i)增加了肺部和脾脏中PP89特异性CD8 + T细胞的大小; (ii)部分地改变,CD127 / KLRG1肺部效应存储器亚群,但脾脏; (iii)在脾脏中改变了CD127 / KRLG1 / CD62L效应器/中央存储器亚群;' (iv)改变pp89 =重新衰弱IFN.gamma / TNF-alpha / IL-2分泌分泌肺部和脾脏; (v)没有影响封装在未加工PP89-RR-EP67上对初级MCMV呼吸道感染的疗效增加的程度。因此,尽管在我们目前的具有MCMV的实验条件下未观察到,但通过选择性增加CD8 + T细胞的记忆子集,可以增加含纳米级可生物降解颗粒的直径与某些病原体的粘膜免疫接种粘膜免疫疫苗的疗效将最强的保护相关。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号